FCGR3A and neoplasm: The soluble targets (e.g. soluble BCMA and CD16a) also likely acted as soluble sinks which, in addition to having a potential impact on RO7297089 PK, may also be affecting the level of free drug that would be available to link NK cells with tumor cells.